173 0 Kommentare Herbalife Nutrition Revises Third Quarter and Full Year 2021 Guidance - Seite 2

The Company will provide greater details and insights about the state and future of the business on Tuesday during its virtual Investor Day. To register, please visit https://ir.herbalife.com/investor-day.

Following is the Company’s updated third quarter and full year 2021 guidance based on current business trends:

	Three Months Ending		Twelve Months Ending
	September 30, 2021		December 31, 2021
	Low	High	Low	High
Volume Point Growth (Decline) vs 2020	(9.0%)	(6.0%)	1.0%	5.0%
Net Sales Growth (Decline) vs 2020 ^(a)	(6.5%)	(3.5%)	4.5%	8.5%
Adjusted Diluted EPS ^{(a) (b) (c)}	$1.00	$1.20	$4.55	$4.95
Adjusted EBITDA ($ millions) ^{(a) (b) (c)}	$200.0	$220.0	$860.0	$910.0
Cap Ex ($ millions)	-	-	$160.0	$200.0

Share Repurchase in Guidance

With respect to guidance, the Company cannot accurately predict the impact to its share base from any future share repurchases. Accordingly, any impact thereof is excluded from the guidance table above.

^(a) Excludes any future potential Venezuela currency devaluations and associated pricing and inflationary consequences.

^(b) Excludes the following items that cannot be accurately predicted: any future potential ongoing tax effects from the exercise or vesting of equity awards that could impact the Company's tax rate due to the stock compensation accounting standard, benefits from future potential China grant income, any future potential dilution from the Company’s convertible notes due in 2024, as well as any future impact of the China Growth and Impact Investment Program.

^(c) Adjusted diluted EPS and adjusted EBITDA guidance are non-GAAP measures and exclude potential charges or gains that may be recorded during the applicable period, such as, among other things, loss contingencies, gain/loss on debt extinguishments and refinancing, tax charges relating to tax law changes, net expenses related to the COVID-19 pandemic, and other unanticipated charges and event. The Company does not provide reconciliations of forward-looking non-GAAP Adjusted EPS and adjusted EBITDA guidance to net income, the comparable GAAP measure because the impact and timing of these potential charges and gains cannot be determined without unreasonable efforts due to their inherent historical variability, complexity, and unpredictability. These items, which are necessary for a presentation of the reconciliation to GAAP, could have a potentially significant impact on the Company’s GAAP results. See Non-GAAP measures below.